Description:

ODM derived from http://clinicaltrials.gov/show/NCT00332852

Link:

http://clinicaltrials.gov/show/NCT00332852

Keywords:
Versions (1) ▾
  1. 12/11/13
Uploaded on:

December 11, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00332852 Breast Cancer

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older, female
Compliant postmenopausal women with primary operable breast cancer after complete surgery and suitable for endocrine treatment
Nodal status negative or positive
Good Health status <=2 (Eastern Cooperative Oncology Group)
Estrogen- and/or progesterone-receptor positive
Adequate marrow, kidney and liver function
Exclusion Criteria
Metastatic or inflammatory breast cancer
Patients with previous or concomitant cancers (not breast cancer) within the past 5 years EXCEPT adequately treated basal or squamous cell skin cancer or in situ cancer of the cervix. Patients with other previous cancers must have been disease-free for at least 5 years and Patients with uncontrolled, non-malignant systemic cardiovascular, kidney, and liver diseases.
Current/active dental problems including infection of the teeth or jawbone, dental or fixture trauma, or a current or prior diagnosis of osteonecrosis of the jaw, of exposed bone in the mouth, or of slow healing after dental procedures.
Recent (within 6 weeks) or planned dental or jaw surgery
Patients with primary overactive parathyroid
Patients with a known hypersensitivity to zoledronic acid or other bisphosphonates.